Fuch's Endothelial Corneal Dystrophy in Cataract Patients Is Associated with Elevated Levels of Inflammatory Chemokines, but Not Growth Factors, in the Aqueous Humor
Overview
Chemistry
Molecular Biology
Affiliations
The study investigated a profile of chemokines and growth factors in the aqueous humor (AH) of eyes with Fuch's endothelial corneal dystrophy (FECD) and cataracts in comparison with cataract patients as a control group. A total of 52 AH samples (26 FECD + cataract and 26 cataract/control) were collected before cataract surgery. None of the patients had any clinically apparent inflammation at the time of AH collection. The AH levels of MCP-1 (CCL2), MIP-1α (CCL3), MIP-1β(CCL4), RANTES (CCL5), eotaxin (CCL11), IP-10 (CXCL10), FGF basic, G-CSF, GM-CSF, PDGF-bb, and VEGF were compared between the groups. The analyses were performed using the Bio-Plex 200 System from Bio-Rad. Among the studied parameters, the AH levels of RANTES, eotaxin, and IP-10 significantly increased in the FECD + cataract eyes, compared with the cataract controls ( < 0.05). Elevated levels of the RANTES, Eotaxin, and IP-10 indicate more intense inflammation in the eyes of patients in the FECD + cataract group. Moreover, these factors exhibit potential as predictive biomarkers for early detection of FECD in cataract patients. The discovery of elevated concentrations of biochemical markers in a patient, who has not yet received a clinical diagnosis, may suggest the need for heightened observation of the other eye to monitor the potential development of FECD.
Wei B, Hu X, Shu B, Huang Q, Chai H, Yuan H Lipids Health Dis. 2025; 24(1):48.
PMID: 39953544 PMC: 11827319. DOI: 10.1186/s12944-025-02470-4.
Chychko L, Son H, Friedrich M, Khoramnia R, Auffarth G, Augustin V Ophthalmol Ther. 2024; 14(1):197-209.
PMID: 39581953 PMC: 11724821. DOI: 10.1007/s40123-024-01072-0.
De Piano M, Abicca I, Dinu V, Roszkowska A, Micera A, Schiano-Lomoriello D J Clin Med. 2024; 13(13).
PMID: 38999352 PMC: 11242089. DOI: 10.3390/jcm13133787.
Fiolka R, Wylegala E, Toborek M, Adamczyk-Zostawa J, Czuba Z, Wylegala A J Clin Med. 2024; 13(10).
PMID: 38792359 PMC: 11121793. DOI: 10.3390/jcm13102815.